Skip to content
GLP-1 Scorecard
Menu

Compare alternative providers

Alternatives to Effecty

Effecty grades B (83.7/100), #21 of 515 on our scorecard. Start with the treatment options and terms below. The available semaglutide price for this provider does not establish a comparable monthly total.

Offer review: November 2026. Factor scores were not reassessed in this update.

You're comparing against

Effecty →
Or visit Effecty directly ↗

The Effecty review sets out what its listed price includes, and the Effecty vs RxSpan MD and Effecty vs Gala Health head-to-heads put it beside the two programs closest to it on price, features and score. The cards below list the rest in the same order, with each one's price conditions.

Of the sellers that pay us a commission, the yourEra review covers one graded close to Effecty, at 83.8/100. That relationship never changes a grade, and the review lists what we could not verify.

Featured alternative

CoreAge Rx scores 89.5/100. Check the price conditions and care terms against Effecty. Use the Effecty review to see which prices and terms are known before treating a lower starting price as a saving.

CoreAge RxGraded #1Featured

Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Product page from $79/mo; navigation $99. Confirm selected quote. sema · From $129/mo advertised; confirm selected charge, supply and renewal. tirzUS only; therapy-specific state restrictions apply+5.8 vs Effecty

More options to compare

RxSpan MDGraded #4

RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Current compounded quote unconfirmed sema · Current compounded quote unconfirmed tirzConfirm treatment availability during intake+0.6 vs Effecty
Gala HealthGraded #11
Factor scores not reassessed.

Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.

From $69/mo on the annual plan, billed once a year (campaign shows $129/mo; offers conflict—confirm billing term) sema · From $99/mo on the annual plan, billed once a year (campaign shows $179/mo; offers conflict—confirm term) tirzCoverage wording differs: all 50 on homepage, most U.S. states in campaign-0.8 vs Effecty
EdenGraded #16

Eden advertises lower-priced compounded bundles, but its offer and linked membership and warranty terms need to be reconciled before purchase.

Advertised $99/mo bundle; linked membership terms conflict—confirm checkout sema · Advertised $129/mo bundle; linked membership terms conflict—confirm checkout tirzAll 50 states-2.1 vs Effecty

FDA warning letter on recordWarning letter issued to Eden Health International Inc. dba Eden in June 2026. The dated notice is in the review.

BiltRxGraded #59
Factor scores not reassessed.

BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.

$82/mo advertised medication starting price; confirm care and shipping charges sema · $130/mo advertised medication starting price; confirm care and shipping charges tirzAll 50 states advertised-8.4 vs Effecty
PlushCareGraded #67

PlushCare suits shoppers who want a physician video visit and pharmacy choice, but membership, appointments, medication and labs are separate costs.

Varies (branded prescription; visits and advertised membership separate) sema · Varies (branded prescription; visits and advertised membership separate) tirzAll 50 states-9.2 vs Effecty

The 6 alternatives above offer other options to compare with Effecty. Every provider we grade — all 515 of them — is scored on the same six factors: browse every graded provider.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard